Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-162
Closed -$6.84K 1169
2026
Q1
$6.84K Buy
+162
New +$7.58K ﹤0.01% 949
2025
Q3
Sell
-9
Closed -$451 1118
2025
Q2
$451 Hold
9
﹤0.01% 973
2025
Q1
$604 Hold
9
﹤0.01% 1010
2024
Q4
$712 Hold
9
﹤0.01% 1004
2024
Q3
$773 Hold
9
﹤0.01% 1041
2024
Q2
$618 Hold
9
﹤0.01% 966
2024
Q1
$556 Sell
9
-45
-83% -$2.4K ﹤0.01% 936
2023
Q4
$2.65K Sell
54
-22
-29% -$1.03K ﹤0.01% 896
2023
Q3
$3.34K Buy
76
+22
+41% +$946 ﹤0.01% 902
2023
Q2
$2.19K Hold
54
﹤0.01% 911
2023
Q1
$2.5K Hold
54
﹤0.01% 906
2022
Q4
$2.62K Hold
54
﹤0.01% 843
2022
Q3
$2K Sell
54
-16
-23% -$607 ﹤0.01% 926
2022
Q2
$2K Buy
70
+13
+23% +$545 ﹤0.01% 972
2022
Q1
$2K Sell
57
-45
-44% -$1.49K ﹤0.01% 991
2021
Q4
$3K Buy
+102
New +$2.97K ﹤0.01% 997

Other funds holding SLVM

HM Payson & Co's SLVM Position: Q2 2026 in Review

HM Payson & Co sold out of Sylvamo (SLVM) in Q2 2026, closing a stake of 162 shares — an estimated $6.84K sold.

HM Payson & Co first reported a position in SLVM in Q4 2021 and held it in 16 quarters. The position peaked at $6.84K in Q1 2026. 48 funds tracked by Wall St. Rank hold SLVM as of Q2 2026.

  • HM Payson & Co reported no remaining Sylvamo position as of Q2 2026 after selling out during the quarter.
  • HM Payson & Co sold 162 Sylvamo shares in Q2 2026, an estimated $6.84K.
  • HM Payson & Co first reported a position in Sylvamo in Q4 2021 and held it in 16 quarters.
  • HM Payson & Co's Sylvamo position peaked at $6.84K in Q1 2026.
  • 48 funds tracked by Wall St. Rank held Sylvamo as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.